Events

You can visit MedGyn at:

SGO 2015

March 28-31
Chicago, IL, USA


ACOG 2015

May 2-6
San Francisco, CA, USA


You can follow us at:


About MedGyn 800.451.9667

Since 1975, MedGyn has been committed to improving women’s healthcare. We develop superior quality medical products to satisfy the needs of leading obstetrics and gynecology medical professionals around the world.

We are focused on better health outcomes for women, which is why we partner with professionals to continually deliver innovative products and the best medical device technology.

We offer a full range of high-quality obstetrics and gynecology products including disposables, instruments and equipment. Our line includes products to treat cervical cancer, including our colposcopes and cryotherapy system; obstetrics products including fetal monitors, dopplers and ultrasounds; urogynecology products including pessaries; as well as a variety of other disposables and instruments.

 

Product Catalog

Product Videos


Alt text

Alt text

 

Company News

SAN DIEGO – An estimated 26-33 million prescriptions for compounded, non–FDA-approved menopausal hormone therapy are filled in the United States e... More » [...]

The health insurance giant UnitedHealthcare will soon require physicians to obtain prior authorization for hysterectomies, except vaginal hysterectomi... More » [...]

Researchers have developed nomograms based on a variety of newly identified prognostic factors – tools that can enhance clinicians’ estimates of 2... More » [...]

Paclitaxel plus carboplatin was noninferior to paclitaxel plus cisplatin in extending overall survival in incurable metastatic or recurrent cervical c... More » [...]

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to support proposed recommendations for use of t... More » [...]

A large prospective study found that among 89,918 women aged 50-79 years, bisphosphonate use was inversely associated with age-adjusted endometrial ca... More » [...]

The prevalence of uterine cancer was 0.09% among women who underwent myomectomy with electric power morcellation, according to the results of a large ... More » [...]

The immunogenicity and efficacy of the recently approved 9-valent human papillomavirus vaccine were similar to that of the currently approved and reco... More » [...]

PARIS – Although survival remains relatively poor, the options for the management of metastatic, recurrent, or persistent cervical cancer have incre... More » [...]

An estimated 14.1 million new cancer cases and 8.2 million cancer deaths occurred in 2012, although incidences of certain cancers, such as lung cancer... More » [...]

 


Copyright © 2015. MedGyn Products, Inc. All Rights Reserved.
100 W Industrial Rd., Addison, IL 60101 USA    
Main: 630.627.4105   Toll-Free: 800.451.9667   Fax: 630.627.0127   Email: info@medgyn.com